Isodiol International Inc. logo

Isodiol International Inc. (ISOLF)

Market Closed
11 Aug, 20:00
OTCQB OTCQB
$
0. 00
0
0%
$
4.91K Market Cap
- P/E Ratio
- Div Yield
500 Volume
0 Eps
$ 0
Previous Close
Add Transaction
Day Range
0 0
Year Range
0 0
Want to track ISOLF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ISOLF closed yesterday higher at $0, an increase of 0% from Monday's close, completing a monthly increase of 0% or $0. Over the past 12 months, ISOLF stock gained 0%.
ISOLF is not paying dividends to its shareholders.
The last earnings report, released on Dec 31, 2016, missed the consensus estimates by -0.2068%. On average, the company has fell short of earnings expectations by -0.1803%, based on the last three reports.
Isodiol International Inc. has completed 2 stock splits, with the recent split occurring on Jul 24, 2018.
The company's stock is traded on one exchange.

ISOLF Chart

People also search for

International Isotopes Inc.
$ 0.07
0%
Starco Brands Inc.
$ 0.04
+5.7143%
Noble Roman's Inc.
$ 0.65
-4.4118%
Fluent Corp.
$ 0.02
-12%
Adm Endeavors Inc.
$ 0.04
-12%

Isodiol International Inc. (ISOLF) FAQ

What is the stock price today?

The current price is $0.00.

On which exchange is it traded?

Isodiol International Inc. is listed on OTCQB.

What is its stock symbol?

The ticker symbol is ISOLF.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 4.91K.

Has Isodiol International Inc. ever had a stock split?

Isodiol International Inc. had 2 splits and the recent split was on Jul 24, 2018.

Isodiol International Inc. Profile

Specialty Retail Industry
Consumer Discretionary Sector
Marcos Agramont CEO
OTCQB Exchange
46500L200 CUSIP
CA Country
- Employees
- Last Dividend
6 Jan 2016 Last Split
- IPO Date

Overview

Isodiol International Inc. is a company at the forefront of the development, marketing, and distribution of hemp-based consumer packaged goods and solutions primarily in Canada and the United States. The enterprise specializes in crafting phytoceutical consumer products that adhere to pharmaceutical and nutraceutical grade standards, utilizing phytochemical compounds. Operating from its headquarters in Vancouver, Canada, Isodiol is a pivotal player in the burgeoning hemp product market, leveraging cutting-edge technology and innovative practices to meet consumer demand for high-quality, hemp-derived products.

Products and Services

  • Pharmaceutical Grade Cannabinoid Crystalline Isolates: These are high-purity cannabinoid products derived from exempt parts of the hemp plant. They are geared towards consumers looking for potent and pure CBD products.
  • Micro-encapsulations and Nanotechnology: This technology is utilized for both consumable and topical skin care products, ensuring enhanced absorption and efficacy of the hemp-based ingredients.
  • Hemp Oil and Nicotine E-Liquids: The company manufactures and distributes a range of e-liquids for vaping devices, including both nicotine and hemp oil varieties. These products cater to the growing demand for alternative smoking options.
  • Personal Care Products: Isodiol's commitment to leveraging hemp's benefits extends to the personal care market, where it offers products that capitalize on hemp's properties for skin care and overall wellness.
  • Apparel and Merchandising Solutions: Beyond consumables and personal care, Isodiol provides branded apparel and merchandising, allowing for brand exposure and consumer engagement beyond traditional retail products.
  • Hemp Infused Beverages: The company has also ventured into the beverage market, offering hemp-infused drinks that offer the benefits of hemp in a consumable, refreshing format.
  • Pharmaceutical Products Supply: Isodiol supplies pharmaceutical-grade products, indicating its capability to meet strict quality and regulatory standards for health and wellness products.

Contact Information

Address: 200 Granville Street
Phone: 604 409 4409